Status:
UNKNOWN
Diet and Other Non Pharmacological Interventions to Reduce Cardiovascular Risk in Hypertensive Patients
Lead Sponsor:
Hospital Universitário Clementino Fraga Filho
Collaborating Sponsors:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Conditions:
Hypertension
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effectiveness of diet change and other non-pharmacological treatments which includes physical activity and integrative therapies oriented to reduce the blo...
Detailed Description
Despite advances in the pharmaceutical industry, blood pressure control remains the biggest challenge in the treatment of hypertension in Brazil and worldwide. In this context, besides the availabilit...
Eligibility Criteria
Inclusion
- Individuals of both sexes aged between 20 and 65 years old;
- Resistant hypertensive individuals: hypertensive individuals using 3 antihypertensive drugs or more without control of office blood pressure (BP ≥ 140 x 90 mmHg) or using 4 drugs with pressure control in follow-up at Hypertension Program (ProHArt) - University Hospital (HUCFF) - Federal University of Rio de Janeiro (UFRJ).
- Pre-hypertensive individuals: individuals with systolic blood pressure (SBP) between 121-139 mmHg and / or diastolic blood pressure (DBP) between 81-89 mmHg without the use of antihypertensive drugs registered at Family Health Strategy unit.
- Hypertensive: individuals with SBP ≥ 140 mmHg and / or DBP ≥ 90 mmHg or using antihypertensive drugs registered at Family Health Strategy unit.
- Individuals who accept to participate in the research after signing the Free and Informed Consent Form
Exclusion
- Pregnant;
- Major cardiovascular events (acute myocardial infarction, unstable angina, stroke) in the last 6 months;
- Individuals with psychiatric illnesses or significant cognitive impairment;
- Individuals with clinical conditions that preclude physical activity such as severe peripheral arterial disease, advanced osteoarticular disease, neurological degenerative disease, severe muscle disease;
- Individuals who have undergone weight loss procedures (diet or medication) in the last 6 months;
- Individuals who have undergone surgical procedures for weight loss;
- Individuals who are participating in any other intervention study.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04746118
Start Date
April 1 2021
End Date
April 1 2023
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitário Clementino Fraga Filho
Rio de Janeiro, Brazil, 21941-913